Skip to main content
. 2023 Oct 4;193(2):705–719. doi: 10.1007/s11845-023-03517-0

Table 2.

Table of secondary outcomes

Secondary outcomes
Need for intervention (endoscopic, surgical and radiological)
Need for therapeutic endoscopic intervention
Need for surgical intervention
Rebleeding rate
Transfusion requirement
Volume of transfusion
Overall length of stay (LOS)
ICU length of stay
Venous thromboembolic events (DVT, PE)
Arterial thromboembolic events (e.g. MI, stroke)
Other adverse effects of tranexamic acid